Institution view

Inge Marie Svane

Programs currently tracked for this institution in the public Translational Deal Radar dataset.

Adoptive Cell Therapy

Autologous tumor-infiltrating lymphocytes

Autologous tumor-infiltrating lymphocytes is flagged as a platform signal because it has an active early-phase oncology cell-therapy trial at Inge Marie Svane, with a possible patent signal linked through modality_match. Manual review is still required.

Phase1 · Completed

View asset